jQuery Slider


Pharmaceutical Cluster in India

India's Pharma market accounts for about 1.4% of the global pharma industry in value terms and 10% in volume terms;

India's Pharma market is expected to grow at a CAGR of 14.5 % over 2009-20 and reach USD 55 Billion to become 3rd largest pharma market. Its is presently 6th largest market;

India's Generics market is expected to grow to USD 26.1 Billion by 2016 with a 7.2% market share

India Formulations market is one of the largest in the world in terms of volume, with 14% market share. Globally 90% of formulations approvals have been granted to Indian Companies;

India's Biosimilar's market is expected to touch USD 1.4 billion in 2016 from USD 482 million in 2011.



Industrial Development Possibilities in Maharashtra




Outlook for Steel for Medium term till 2017-18 & Strategy for hedging and procurements.

Global economic growth is the main determinant for the increase in prices for the steel and other base metals. Over the medium term period they move as a group. The outperformance or underperformance on the price, relatively in the group, would depend on the demand and supply situation of each of the commodities and the input cost.

Global economy has grown sharply during the period 2002-2008 mainly led by the consumption growth from the private and government sector. The high growth was recorded for lobal economy rising at about 5% consistently, which is a historical achievement. During this time consumption growth was strong, governments had reduced interest rate to further fuel the demand and price increase. Commodities zoomed to unprecedented levels. Other factor responsible for the same was under capacity. The sector was in bear phase for almost 20 years before its turnaround in 2002-03.